>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance:

SNCR -15.9%, LPSN -15.2%, FSC -13.4%, MTRX -10.6%, MB -10.5%, QLYS -9.1%, TWTR -8.9%, IRBT -8.8%, BGC -8%, VSTO -7.6%, SON -7.5%, OII -7%
MXL -6.9%, LQDT -6.8%, GLUU -6%, STRL -5.8%, (sees Q4 net loss of $5.5-6.5 mln and revs of $165-170 mln vs. $157.25 mln two analyst estimate; says results are 'very disappointing')
ECHO -5.3%, COTY -5.2%, ENSG -5%, TYL -4.8%, CDE -4.2%, TBI -3.6%, KS -3.4%, ENTA -3.3%, UHAL -3%, MC -3%, SNN -2.9%, FSFR -2.8%, FISV -2.6%
PPC -2.1%, KO -2.1%, GLAD -1.7%, AGTC -1.5%, MAS -1.5%, CTL -1.4%, PDS -1.3%, DTE -1.2%, REGN -1.2%, JE -1%, CX -0.6%, SEE -0.5%

Other news:

SRRA -9.1% (to offer shares of its common stock in an underwritten public offering; size not disclosed)
CREE -5.5% (CFIUS informed Infineon and Cree that the Wolfspeed transaction poses a risk to the national security of the United States)
AMGN -1.4% (Regeneron Pharma confirms appeals court grants stay of permanent injunction for Praluent (alirocumab) during appeals process)
REGN -1.2% (Regeneron Pharma confirms appeals court grants stay of permanent injunction for Praluent (alirocumab) during appeals process)
TM -1.2% (traded ~2% lower in Japan overnight)
HLI -1.1% (prices offering of 8 mln shares of common stock by co and selling shareholders at $29.25 per share)
FSLR -1% (awarded module supply contract for the 140 megawatt DC Sun Metals Solar Farm in North Queensland)
PYPL -0.9% (discloses that it has received subpoenas from the DOJ seeking the production of certain information related to the company's historical anti-money laundering program)
KR -0.9% (WFM sympathy)

Analyst comments: